Sample size considerations for trials using cerebral white matter hyperintensity progression as an intermediate outcome at 1 year after mild stroke: results of a prospective cohort study

BACKGROUND: White matter hyperintensities (WMHs) are commonly seen on in brain imaging and are associated with stroke and cognitive decline. Therefore, they may provide a relevant intermediate outcome in clinical trials. WMH can be measured as a volume or visually on the Fazekas scale. We investigat...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Trials
Main Authors: Chappell, Francesca M., del Carmen Valdés Hernández, Maria, Makin, Stephen D., Shuler, Kirsten, Sakka, Eleni, Dennis, Martin S., Armitage, Paul A., Muñoz Maniega, Susana, Wardlaw, Joanna M.
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2017
Fag:
Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5320698/
https://ncbi.nlm.nih.gov/pubmed/28222778
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-017-1825-7
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker